Logiscreen

Pacira BioSciences Inc

$22.75
Market Cap 978.73M
ROE 0.7%
Gross Margin 79.5%
Debt/Equity 0.6
Current Ratio 4.7
Revenue QoQ 5.0%
EPS QoQ -0.3%
F-Score 5

About

Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
189.82
vs median 31.50
P/B
1.49
vs median 2.17
ROE
0.01
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics